Related Experiment Video

Updated: Jul 13, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

TRAFs in RANK signaling

Bryant G Darnay1, Arnaud Besse, Ann T Poblenz

  • 1Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. bdarnay@mdanderson.org

Advances in Experimental Medicine and Biology
|July 18, 2007
PubMed

Insights

Tumor Necrosis Factor (TNF) family members regulate cell functions via specific receptors and adaptor molecules. Receptor Activator of Nuclear factor-kappa B (RANK) and its ligand (RANKL) signaling critically depend on TRAF6 for linking cellular signals to nuclear transcription.

Area of Science:

  • Cellular Biology
  • Immunology
  • Molecular Biology

Background:

  • The Tumor Necrosis Factor (TNF) superfamily regulates critical cellular processes like proliferation, differentiation, and apoptosis.
  • TNF ligands bind to receptors lacking enzymatic activity, necessitating adaptor molecules for signal transduction.
  • Receptor Activator of Nuclear factor-kappa B (RANK) and its ligand (RANKL) are key regulators of bone remodeling, mammary gland development, and lymph node organogenesis.

Purpose of the Study:

  • To elucidate the role of TNF receptor-associated factors (TRAFs) in RANK/RANKL signaling pathways.
  • To identify the critical adaptor molecule(s) mediating RANKL-induced cellular responses.
  • To understand how RANKL signaling connects to downstream nuclear transcriptional programs.

Main Methods:

  • Investigated the interaction between RANK and various TRAF family members.
  • Focused on the functional significance of TRAF6 in RANK-mediated signaling.
  • Analyzed the downstream effects of RANKL stimulation on cellular signaling pathways.

Main Results:

  • RANK signaling is dependent on the association with specific TNF receptor-associated factors (TRAFs).
  • TRAF6 was identified as an indispensable adaptor molecule for RANK signaling.
  • Evidence suggests TRAF6 is crucial for transmitting RANKL signals to the nucleus, influencing transcription.

Conclusions:

  • TRAF6 plays a pivotal role in the RANKL signaling pathway.
  • Understanding TRAF6 function is key to deciphering how RANKL regulates gene expression.
  • This research highlights TRAF6 as a central mediator in TNF family signaling pathways relevant to development and homeostasis.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...